Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum

Biochemical and Biophysical Research Communications

Volumn 386, Issue 3, 2009, Pages 477-482

  Kawanami, Aya ^a   Matsushita, Takehiko ^a   Chan, Yuk Yu ^a   Murakami, Shunichi ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chondrogenesis; CreER; Fracture healing; GFP; Osteochondro progenitor; Osteogenesis; Perichondrium; Periosteum; Tamoxifen

Indexed keywords

CRE RECOMBINASE; FIBROBLAST GROWTH FACTOR 18; GREEN FLUORESCENT PROTEIN; PROTEIN; PROTEIN PRX1; TENASCIN; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CALLUS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL SUBPOPULATION; CHONDROGENESIS; DIAPHYSIS; EMBRYO; LIMB BUD; LIMB DEVELOPMENT; MOUSE; NONHUMAN; OSTEOBLAST; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CHONDROCYTES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; INTEGRASES; MICE; MICE, TRANSGENIC; OSTEOBLASTS; PERIOSTEUM; PROTEINS; STEM CELLS;

MUS; MUS MUSCULUS;

EID: 67650064589     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.059     Document Type: Article

References (11)

1. Bandyopadhyay A., Kubilus J.K., Crochiere M.L., Linsenmayer T.F., and Tabin C.J. Identification of unique molecular subdomains in the perichondrium and periosteum and their role in regulating gene expression in the underlying chondrocytes. Dev. Biol. 321 (2008) 162-174
2. Nakahara H., Bruder S.P., Goldberg V.M., and Caplan A.I. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin. Orthop. Relat. Res. 259 (1990) 223-232
3. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J. Bone Miner. Res. 24 (2009) 274-282
4. Tanenbaum H.C. An ultrastructural study of osteogenesis in chick periosteum in vitro. Bone 7 (1986) 295-302
5. Martin J.F., and Olson E.N. Identification of a prx1 limb enhancer. Genesis 26 (2000) 225-229
6. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., and Tabin C.J. Expression of Cre recombinase in the developing mouse limb bud driven by a Prx1 enhancer. Genesis 33 (2002) 77-80
7. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16 (2002) 2813-2828
8. Feil R., Wagner J., Metzger D., and Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 237 (1997) 752-757
9. Matsushita T., Wilcox W.R., Chan Y., Kawanami A., Bükülmez H., Balmes G., Krejci P., Mekikian P.B., Otani K., Yamaura I., Warman M.L., Givol D., and Murakami S. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Hum. Mol. Genet. 18 (2009) 227-240
10. Bonnarens F., and Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J. Orthop. Res. 2 (1984) 97-101
11. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., Einhorn T., Tabin C.J., and Rosen V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38 (2006) 1424-1429